Use of lipoxin compounds for inhibiting of TNF-(alfa) initiated neutrophil response
A Standard patent application filed on 14 March 2000 credited to Serhan, Charles N.
Details
Application number :
38806
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Use of lipoxin compounds for inhibiting of TNF-(alfa) initiated neutrophil response
Inventor :
Serhan, Charles N.
Agent name :
WATERMARK PATENT AND TRADE MARKS ATTORNEYS
Address for service :
Level 2 302 Burwood Road HAWTHORN VIC 3122
Filing date :
14 March 2000
Associated companies :
Applicant name :
Brigham and Women's Hospital
Applicant address :
75 Francis Street Boston MA 02115 United States Of America